ClinicalTrials.gg
RecruitingNCT04604444Updated Oct 31, 2024

Changes in Neuroplasticity Following Intensive Rehabilitation of Aphasia and/or Apraxia of Speech

An interventional study of Multimodal Intensive Rehabilitation of Aphasia and Apraxia of Speech in Aphasia, Apraxia of Speech and Dysarthria, sponsored by Karolinska Institutet. Recruiting at 1 site in Sweden. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-10-31.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 7 months after the study started (first participant enrolled Feb 2017, registered Sep 2020).
  • Started Feb 2017; still recruiting 9 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The present study aims to investigate the short- and long-term effects of two weeks of intensive speech-language pathology intervention with additional physiotherapy, on aphasia and apraxia of speech (AOS) and their neural correlates in thirty persons with chronic stroke. Changes are studied following intensive treatment of aphasia and AOS with standardised speech-language testing and testing of communication and with voxel-based morphometry (VBM) analysis and resting state functional connectivity (rsFC).

Read the detailed description

This study explores structural and functional brain changes in relation to effects on speech, language, communication and quality of life following an intensive speech-language program with additional physiotherapy for persons with chronic aphasia and/or apraxia of speech. The participants are consecutively recruited from a rehabilitation centre providing intensive treatment for chronic conditions following stroke or other neurological injuries. The speech-language pathologists (SLPs) involved in the rehabilitation programs perform the testing directly before and after intensive intervention with an additional follow up after 16 weeks (+-2) with testing of speech-language, communication and quality of life. The SLPs have more than five years of experience of working with aphasia and are specialised in working with intensive treatment, they have acquired in-depth knowledge on how to evaluate and treat aphasia and apraxia of speech in lectures and workshops. The test procedure is recorded with camcorder and voice recorder to provide the opportunity to access data retrospectively and to minimize bias by including an external SLP who makes a second blinded evaluation on randomized participants' performance in ASRS, BNT and CAT by studying the video and voice material. Structural and functional neuroplasticity is also investigated with voxel-based morphometry (VBM) analysis, resting state functional connectivity (rsFC) in domain-specific (language processing) and domain-general (executive and attention processing). This intensive neuro-rehabilitation program for speech and language deficits named Multimodal Intensive Rehabilitation for Aphasia and Apraxia of Speech (MIRAA) is defined as an ICAP (Intensive Comprehensive Aphasia Program) with focus on both speech and language function and communicative activity and participation. The program is intensive: consisting of ten days of training (5 hours/day), with a minimum of three hours dedicated to speech and language rehabilitation with additional physical therapy. The program includes both individual treatment, group therapy and computer-based therapy. The therapy is individually set up after the participant's goals together with the team including SLPs, physiotherapists and a board-certified neurologist and/or specialist in rehabilitation medicine. The goals are set by the participants, family members and clinicians the first day of the program. The participant and their significant other are offered education with the aim to enhance the knowledge on communication, the key concepts of neuroplasticity and other functions and strategies important in everyday life. The treatment methods being used are evidence-based and/or widely used multimodal programs covering the need for extensive training programs targeting both impairment-based therapy and functional communication. The specific questions are: Does ten days of with an intensive comprehensive aphasia/AOS program result in any clinical significant improvements in speech and/or language function and other cognitive skills for participants with chronic aphasia and/or apraxia of speech? Does the intensive intervention have any effect on the quality of everyday life concerning speech and language functions, activity and communicative participation for people with chronic aphasia and apraxia of speech? Can functional and anatomical brain changes be detected following ten days of intensive speech and language intervention for these participants?

02

Conditions studied

  • Aphasia
  • Apraxia of Speech
  • Dysarthria

Keywords

  • Intensive Aphasia Rehabilitation
  • Intensive Apraxia of Speech Rehabilitation
  • Neuroplasticity
03

In context

Aphasia

338 studies on the registry are indexed under Aphasia; 95 are open to participants now.

This study's planned enrollment of 30 is close to the median of 30 across 298 interventional studies indexed under Aphasia.

Browse Aphasia studies →

Lead sponsor

Karolinska Institutet is the lead sponsor of 1,148 studies on the registry; 276 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aphasia 7 months post stroke diagnosed by SLP
  • Apraxia of Speech 7 months post stroke diagnosed by SLP

Exclusion criteria

Exclusion Criteria:

  • Dementia
  • Severe loss of sight
  • Severe loss of hearing
  • Metal implants (preventing fMRI)
  • Claustrophobia (preventing fMRI)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Multimodal Intensive Rehabilitation of Aphasia/AOS (MIRAA)

    A minimum of 3 hour speech-language training daily during 10 days.

    Behavioral: Multimodal Intensive Rehabilitation of Aphasia and Apraxia of Speech

Interventions

  • BehavioralMultimodal Intensive Rehabilitation of Aphasia and Apraxia of Speech

    Intensive Comprehensive Aphasia (ICAP) and Apraxia of Speech Program

06

What researchers measure

Primary outcomes

  1. Comprehensive Aphasia Test (CAT) language battery, in pilot Swedish test A-ning.

    Comprehension of spoken language: minimum score 0, maximum score 66; Comprehension of written langugage: minimum score 0, maximum score 62; Repetition: minimum score 0, maximum score 74; Naming: minimum score 0, maximum score no limit; Reading: minimum score 0, maximum score 70; Writing: minimum score 0, maximum score 76. Higher scores mean better outcome in language functions.

    Time frame: Changes from baseline in language battery scores at 2 and 18 weeks.

  2. Rating scale for apraxia of speech (SkaFTA, Swedish version of ASRS)

    Minimum score 0, maximum score 52. Lower scores mean better outcome in speech functions.

    Time frame: Changes from baseline scores at 2 and 18 weeks.

  3. Communication Outcome After Stroke (COAST)

    Minimum score 0, maximum score 100. Higher scores mean better outcome in communication.

    Time frame: Changes from baseline scores at 2 and 18 weeks.

  4. Goal Attainment Scaling (GAS), International Classification of Functioning, Disability and Health (ICF). Aphasia adapted GAS scales for self-evaluation of communication functions, participation and activity.

    Minimum score -2, maximum score +2. Higher scores mean better outcome in quality of life.

    Time frame: Changes from baseline at week 18.

Secondary outcomes

  1. Barrow Neurological Institute Screening for Higher Cerebral Function (BNIS)

    Minimum score 0, maximum score 50. Higher scores mean better outcome in cognition.

    Time frame: Changes from baseline at week 2

  2. Boston Naming Test (BNT)

    Minimum score 0, maximum score 60. Higher scores mean better outcome in naming ability.

    Time frame: Changes from baseline at week 2 and week 18.

  3. Protocol for Apraxia of Speech (TAX)

    Minimum score 0, maximum score 30. Lower scores mean mean better outcome in speech functions and non verbal oral apraxia.

    Time frame: Changes from baseline at week 2 and week 18.

  4. Comprehensive Aphasia Test (CAT), subtest cognitive screening

    Minimum score 0, maximum score 38. Higher scores mean better outcome in cognitive functions.

    Time frame: Changes from baseline in Comprehensive Aphasia Test cognitive screening scores at 2 and 18 weeks.

07

Study locations

1 of 1 sites recruiting
  • Uppsala Universitet
    Uppsala, 141 86, Sweden
    Recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — All individual patient data (IPD) that underlie results in a publication.

Supporting information: Study protocol, Informed consent form, Analytic code

Time frame: 2020-2030

Access criteria: Swedish National Data Service open source http://snd.gu.se/sv/dashboard/data-description/0a1f0ee0-454e-4d66-b43f-b235bfe821a6#publications

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2017 (actual). Primary completion is estimated for Dec 2026, 118 months after the start.

Of 183 non-industry interventional studies with no phase under Aphasia, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 57. This study's planned 118 months is above that.

Counting every sponsor, half of 185 studies reached it within 36 months; a quarter within 20 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 11, 2020
First posted
Oct 27, 2020
StartActual
Feb 2, 2017
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2027
Last update
Oct 31, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 31, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04604444
Responsible party
Ellika Schalling (Professor, Speech Language Pathologist, Karolinska Institutet) — Principal investigator
First posted
Oct 27, 2020
Start date
Feb 2, 2017
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Oct 31, 2024

Study contacts

Marika J Schütz, Ph.D student
Contact
marika.schutz@uu.se
0046737570430
Ellika Schalling, Professor
principal investigator · Uppsala University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion